Surgical resection of lung adenocarcinoma after crizotinib treatment: report of a case

A 45-year-old female was diagnosed as having lung adenocarcinoma harboring an anaplastic lymphoma kinase (ALK) rearrangement, stage IV (T2bN3M1b). She was treated with crizotinib as second-line chemotherapy. The clinical stage after crizotinib treatment was ycT2aN0M0, stage IB. We performed a left l...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaseda, Kaoru, Watanabe, Ken-ichi, Asakura, Keisuke, Kazama, Akio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342155/
https://www.ncbi.nlm.nih.gov/pubmed/25889062
http://dx.doi.org/10.1186/s12957-015-0480-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342155/
https://www.ncbi.nlm.nih.gov/pubmed/25889062
http://dx.doi.org/10.1186/s12957-015-0480-2

Ejemplares similares